This company is a pharmaceutical manufacturer operating in the European market for over two decades. They specialize in producing generic medications, encompassing a broad range of therapeutic areas including gastrointestinal health, allergy and hayfever, and CNS treatments. Their production lines include Rx and OTC products in various dosage forms like solids, liquids, and injectables. They also have GMP approvals from both EU and USA. The company boasts a strong track record of success, highlighted by their recent revenue exceeding £90 million and their recognition as a "Large Business of the Year" in 2015.

Established in 1967, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 21 countries and regions. With a dedicated team of over 500 employees, it operates four GMP-certified facilities in Melaka, Malaysia, producing a diverse range of products including tablets, capsules, powders for oral suspensions, liquids, creams, ointments, and sterile eye drops. As a GMP manufacturer, it holds certifications such as EU GMP, PIC/S GMP, TGA GMP, ISO 13485, ISO 9001, ISO 17025, and Halal, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​